Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06804759 · ClinicalTrials.gov registry record · NA

A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the Signs of Aging

A NA study of Skin Aging, sponsored by Victoria Collotta.

Active
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06804759 is a NA study of Skin Aging that is active but no longer recruiting, run by Victoria Collotta. The registered enrollment target is 40 participants, below the 71-participant average among 9 other Skin Aging trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06804759, a NA study of Skin Aging, is active but no longer recruiting, sponsored by Victoria Collotta.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

A clinical study with approximately 40 subjects, aged 35-65 years of age, who must have crow's feet and at least one other type of facial fine lines/wrinkles in order to evaluate the efficacy of Activated Silk™ 27P-α to improve the signs of aging.

Conditions Studied

Interventions

  • OTHER Investigational Facial Serum #1
  • OTHER Investigational Facial Serum #2
  • OTHER Investigational Facial Serum #3

Study Locations (1)

Massachusetts

  • Evolved By Nature - Needham

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-11-18
Est. Completion 2025-01
Phase NA

Sponsor

Victoria Collotta

2 total trials

What the Registry Record Tells You About NCT06804759

The ClinicalTrials.gov registry entry for NCT06804759 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 71-participant average among 9 other Skin Aging trials with a reported enrollment target (44% lower). The listed sponsor is Victoria Collotta, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Skin Aging appearing as the primary indexed condition, and to 3 interventions - of which Investigational Facial Serum #1 is the first listed.

NCT06804759 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06804759 about?

NCT06804759 is a clinical study titled "A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the Signs of Aging". A clinical study with approximately 40 subjects, aged 35-65 years of age, who must have crow's feet and at least one other type of facial fine lines/wrinkles in order to evaluate the efficacy of Activated Silk™ 27P-α to improve the signs of aging.

What is the current status of trial NCT06804759?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-11-18. Estimated completion is 2025-01.

What conditions does trial NCT06804759 study?

This clinical trial studies the following conditions: Skin Aging.

What interventions are being tested in trial NCT06804759?

The interventions under investigation include: Investigational Facial Serum #1 (OTHER), Investigational Facial Serum #2 (OTHER), Investigational Facial Serum #3 (OTHER).

Who is sponsoring clinical trial NCT06804759?

This trial is sponsored by Victoria Collotta, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06804759 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Skin Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.